Want to join the conversation?
U.S. pharmaceuticals distributor $MCK said that it has agreed to acquire cancer-care services provider Vantage Oncology LLC and oncology pharmacy services company Biologics, Inc. The combined transactions, valued at $1.2Bil, will be funded by a mix of cash and incremental debt and are expected to close in 1Q17.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.